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  INTRODUCTION 
  Epigenetics is heritable and reversible changes in gene expres-
sion without altering DNA sequence. The mechanisms of 
epigenetic modifications include histone acetylation, histone 
methylation, and DNA methylation, and these modifications 
provide a way to control the expression of genes involved in vari-
ous cellular functions.  1,2   Enzymes involved in these epigenetic 
mechanisms are: histone acetyltransferases, histone deacetylases 
(HDACs), histone methyltransferases, and DNA methyltrans-
ferases (DNMTs). When histones are acetylated, transcription 
factors can access DNA, leading to gene transcription, whereas 
deacetylated histones lead to condensed (or closed) chromatin 
structure, making DNA inaccessible to transcription factors and 
preventing gene expression. In addition, histone methylation has 
a pivotal role in the maintenance of both active and suppressed 
states of gene expression, depending on the sites of methyla-
tion. The methylation of histone H3 at lysine-4 and lysine-36 
(H3K4 and H3K36) is implicated in activation of transcription, 
whereas methylation of histone H3 at lysine-9 and lysine-27 
(H3K9 and H3K27) is correlated with repression of transcrip-
tion.  3   Perturbed balance between acetylation  /  deacetylation 
or methylation  /  demethylation leads to aberrant expression of 
key regulators of cell development, disease, and more often 
cancer development. Most of epigenetic studies thus far have 
focused on cancer progression, but the role of host inflamma-
tion on modification of epigenetic patterns is still in its infancy. 
Periodontitis results in an inflammatory reaction of the peri-
odontium to pathogenic microorganisms. A number of Gram-
negative anaerobic bacteria, including  Porphyromonas gingivalis , 
  Tannerella forsythia  , and   Treponema denticola,   are  associated 
with periodontal disease.  4   In addition to bacterial infection, 
genetic and  /  or environmental factors contribute to occurrence 
and progression of periodontal disease.  5,6   Many patients with 
the same clinical symptoms respond differently to the same 
therapy, suggesting interindividual variability observed as the 
clinical outcome of the disease is influenced by genetic  7,8  as well 
as epigenetic factors.  9   Recent studies suggest that epigenetics 
have a critical role in regulating inflammatory responses and 
that the manifestation and severity of periodontal disease may 
be influenced by epigenetic factors.  9,10  
  The innate immune system is the first line of defense against 
invading microorganism by producing antimicrobial peptides, 
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such as human   -defensins (hBDs), which are widely expressed 
in epithelial tissue including oral cavity. They have a broad 
spectrum of activity against Gram-negative and Gram-positive 
bacteria as well as some fungi and virus.  11   In addition to their 
direct effect, hBDs also stimulate antigen-presenting dendritic 
cells and link other innate immune components or adaptive 
immune responses, resulting in efficient and coordinated epi-
thelial barrier function against invading bacteria.  12  Therefore, it 
seems reasonable that periodontal disease could be prevented or 
mitigated by induction of host innate immune function. 
 We have previously reported that exposure of gingival epithe-
lial cells (GECs) to different oral bacteria leads to differential 
induction of downstream innate immune markers and that the 
signaling pathways utilized also differ between bacteria.  13,14  
Therefore, we hypothesize that differential epigenetic changes 
will result from the presence of different oral bacteria and that 
these epigenetic changes could influence the innate immune 
responses in the host. The goal of this study is to investigate 
how epigenetic modifications brought on by exposure to oral 
bacteria, including a periodontal pathogen, affect host innate 
immune responses, such as hBD2 and CC chemokine ligand 20 
(CCL20)  expression.   
  RESULTS   
  Changes in HDAC1, HDAC2, and DNMT1 in response to the 
presence of   P. gingivalis   and   F. nucleatum   
  We first investigated any changes in the expression levels of 
chromatin-remodeling enzymes after GECs were exposed to 
oral bacteria. HDACs remove acetyl groups from histone, lead-
ing to suppression of genes. DNMTs catalyze transfer of methyl 
groups onto DNA, which also leads to gene suppression. First, 
the expression levels of HDAC1, HDAC2, and DNMT1 were 
investigated in human immortalized keratinocyte cell line 
(TERT) at different time points (4 and 24     h) and multiplicities 
of infection (MOIs; 10:1 and 100:1). Quantitative real-time PCR 
(QRT-PCR) analyses showed changes in the expression levels of 
DNMT1, HDAC1, and HDAC2 when TERT cells were treated 
with  P. gingivalis  (a pathogen) or  F. nucleatum  (a bridging organ-
ism between pathogens and nonpathogens) at MOIs of 10:1 and 
100:1 ( Figure 1 ) for 4 and 24   h. The gene expression of HDAC1 
was decreased significantly at MOI 100:1 for 24   h in cells treated 
with  P. gingivalis , but not with  F. nucleatum . The gene expression 
of HDAC2 slightly increased with   F. nucleatum   at  4   h  for  MOI 
10:1. Significant decreases of DNMT1 gene expression levels 
were observed in TERT cells treated with both bacteria at MOI 
of 100:1 for 24     h. As more significant changes were observed at 
24     h, we further compared these results from human immor-
talized cell line with human primary GECs at 24     h and various 
MOIs ( Figure 2 ). The expression level of DNMT1 decreased in 
response to both   P. gingivalis   and   F. nucleatum   ( P     =    0.003  and 
0.006, respectively;  Figure 2a ). This decrease was observed at all 
MOIs tested in response to both   P. gingivalis   and   F. nucleatum . 
This decrease in DNMT1 gene expression was dose depend-
ent in GECs in response to   F. nucleatum  . The gene expression 
level of HDAC1 significantly decreased in GECs when the cells 
were treated with   P. gingivalis   for  24   h  at  all  MOIs  compared 
with unstimulated control (  P     =    0.001;   Figure 2b  ). On the other 
hand, the expression of HDAC1 significantly decreased in GECs 
to the lowest level when treated with   F. nucleatum   for  24   h  at 
MOI 10:1 ( P     =    0.03;  Figure 2b ). The gene expression of HDCA2 
signi  ficantly decreased in GECs in response to   F. nucleatum   at 
MOIs 50:1 and 100:1, whereas only at MOI 100:1 in response to 
  P. gingivalis   ( Figure 2c  ). The decrease of DNMT1 and HDAC2 
gene expression showed similar trends in GECs compared with 
what we observed in TERT cells, whereas the expression of 
HDAC1 in response to   P. gingivalis   and   F. nucleatum   differed 
between the two cell types  .   These data indicate that the gene 
expression of these chromatin-remodeling enzymes may have 
cell type-specific responses. 
  We further confirmed the gene expression of chromatin-
remodeling enzymes (HDAC1, HDAC2, and DNMT1) in GECs 
treated with oral bacteria at the protein levels using western 
blot analyses.   P. gingivalis   (MOI 100:1) significantly decreased 
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    Figure 1                        Differential mRNA expression of HDAC1, HDAC2 and 
DNMT1 in human TERT cells in response to oral bacteria. Differential 
mRNA expression of (  a  ) histone deacetylases 1 and 2 (HDAC1 and 
HDAC2) and (  b  ) DNA methyltransferase (DNMT1) in human TERT cells 
in response to   Porphyromonas gingivalis   vs.   Fusobacterium nucleatum  . 
Human TERT cells were stimulated with   P. gingivalis   (Pg) or   F. nucleatum   
(Fn) at multiplicities of infection (MOIs) of 10:1, 50:1, and 100:1 for 4 or 
24    h. Unstimulated cells at 4 and 24    h served as controls. Changes in 
mRNA expression were evaluated by quantitative real-time PCR (QRT-
PCR) and results are expressed as fold change in gene expression 
compared with the corresponding unstimulated controls (4 and 24    h) 
after normalization with glyceraldehydes-3-phosphate dehydrogenase 
(GAPDH). The experiment was repeated twice using TERT cells. Error 
bars indicate s.e.m. Asterisks indicate statistically significant difference 
compared with unstimulated control (Ctl) (  *    P        <      0.05,   *    *    P        <      0.01).   MucosalImmunology | VOLUME 4 NUMBER 4 | JULY 2011   411
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HDAC1, HDAC2, and DNMT1 proteins in GECs compared 
with the unstimulated controls at 24   h. In contrast,  F. nucleatum  
(MOI 100:1) did not show any effects on the expression of these 
proteins in GECs at 24   h compared with controls ( Figure 3 ). The 
analysis of the protein expression pattern of DNMT1, HDAC1, 
and HDAC2 followed the same trend as the mRNA expression 
in GECs treated with   P. gingivalis .   
  Gene expression of epithelial innate immune markers is 
increased following the inhibition of HDAC and DNMT 
    -Defensins and CCL20 have been known as critical markers 
of innate immune responses against microbial invasion.  15,16  We 
previously reported that   P. gingivalis   and   F. nucleatum   are all 
excellent inducers of hBD-2  13  and CCL20 (also known as MIP3   
(macrophage inflammatory protein-3   )). 17   In order to study 
the downstream response of innate immune markers following 
epigenetic modifications, we tested the effect of the inhibitors 
for chromatin-modifying enzymes followed by bacterial stimu-
lation on the expression of the antimicrobial proteins hBD-2 and 
CCL20. GECs were pretreated with HDAC inhibitors sodium 
butyrate (SB) or trichostatin A (TSA), or DNMT inhibitor 
5    -azacytidine (AZA) before bacterial exposure. Treatment of 
GECs with AZA demethylates DNA, leading to gene activation, 
whereas exposure to SB or TSA results in a higher level of his-
tone acetylation. The gene expression of hBD2 and CCL20 was 
significantly increased in GECs in response to both  P. gingivalis  
and   F. nucleatum  , which is consistent with our previous report 
(  Figures 4 and 5 ). 13,18   Treatment with inhibitors alone did not 
significantly change expression of hBD2 and CCL20 in GECs. 
The inhibitor SB had no effect on the gene expression of hBD2 
and CCL20 in response to these oral bacteria compared with 
relative bacterial treatment alone. Treatment with TSA, another 
HDAC inhibitor structurally unrelated to SB, resulted in signifi-
cantly increased hBD2 and CCL20 gene expression in GECs in 
response to both oral bacteria (  Figures 4b and 5b )  compared 
with the bacterial treatment alone. Combining inhibitors SB 
and TSA synergistically enhanced CCL20 expression in GECs 
(  Figure 5c  ). Treatment with HDAC inhibitors amplified hBD2 
and CCL20 gene expression, thus suggesting that increasing 
histone acetylation will aid innate immune responses in GECs 
in the presence of oral bacteria. Treatment with AZA signifi-
cantly increased gene expression of hBD2 and CCL20 in GECS 
in response to   F. nucleatum,   but not to   P. gingivalis   ( Figures 4d 
and 5d ). Our data suggest that the oral bridging microorganism 
  F. nucleatum   induced hBD2 and CCL20 via both demethyla-
tion and acetylation mechanisms, whereas the induction by oral 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
0.2
0.4
0.6
0.8
1
1.2
P. gingivalis F. nucleatum
DNMT1
HDAC1
HDAC2
** **
*
**
** *
0
0.2
0.4
0.6
0.8
1
1.2
a
b
c
F
o
l
d
 
c
h
a
n
g
e
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
m
R
N
A
 
g
e
n
e
 
e
x
p
r
e
s
s
i
o
n
Ctl 10 50 100 10 50 100
P. gingivalis F. nucleatum
Ctl 10 50 100 10 50 100
P. gingivalis F. nucleatum
Ctl 10 50 100 10 50 100
            Figure 2                        Differential decreased mRNA expression of HDAC1, HDAC2 
and DNMT1 in gingival epithelial cells in response to various doses of 
oral bacteria. mRNA expression of (  a  ) DNA methyltransferase (DNMT1), 
(  b  ) histone deacetylase 1 (HDAC1), and (  c  ) histone deacetylase 
2 (HDAC2) are differentially decreased in gingival epithelial cells 
(GECs) in response to various doses of   Porphyromonas gingivalis   vs. 
  Fusobacterium nucleatum  . GECs were stimulated with   P. gingivalis   (Pg) 
or   F. nucleatum   (Fn) at multiplicities of infection (MOIs) of 10:1, 50:1, 
100:1, and 200:1 for 24    h. Changes in mRNA expression were evaluated 
by quantitative real-time PCR (QRT-PCR) and results are expressed 
as fold change in gene expression compared with the unstimulated 
control after normalization with the housekeeping gene   glyceraldehydes-
3-phosphate dehydrogenase   (  GAPDH  ). The data are derived from 
three different cell donors tested in duplicate. Error bars indicate s.e.m. 
Asterisks indicate statistically significant difference compared with 
unstimulated control (Ctl) (  *    P        <      0.05,   *    *    P        <      0.01).   
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    Figure 3                        Protein levels of histone deacetylases 1 and 2 (HDAC1 
and HDAC2) and DNA methyltransferase (DNMT1) are differentially 
expressed in gingival epithelial cells (GECs) in response to 
  Porphyromonas gingivalis   (Pg) and   Fusobacterium nucleatum   (Fn). 
GECs were stimulated with   P. gingivalis   (Pg) or   F. nucleatum   (Fn) at 
multiplicities of infection (MOIs) of 100:1 for 24    h. Nuclear proteins were 
extracted, denatured at 70      °  C for 10    min, and separated by NuPAGE 
electrophoresis system. Nuclear extracts of Hela cells probed with 
individual primary antibody were used as positive controls. The data are 
derived from two different cell donors tested in duplicate.    412  VOLUME 4 NUMBER 4 | JULY 2011 | www.nature.com/mi
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pathogen   P. gingivalis   is only via acetylation mechanism. Thus, 
taken together, our data suggest that epithelial innate immune 
responses (hBD2 and CCL20) are regulated by epigenetic modi-
fications, and these responses are bacteria specific.     
  Differential increase of interleukin-8 (IL-8) secretion following 
the inhibition of HDAC and DNMT 
  To determine whether an increase in histone acetylation or 
demethylation would also induce additional immune responses 
in GECs, IL-8 secretion was measured (  Figure 6 ).  Stimulation 
with   F. nucleatum   resulted in the increased level of IL-8 secre-
tion, whereas   P. gingivalis   decreased IL-8 secretion, which is in 
agreement with our earlier finding. IL-8 secretion was signifi-
cantly increased when GECs were pretreated with HDAC inhibi-
tor SB or TSA followed by exposure to   P. gingivalis,   but not to 
  F. nucleatum  , compared with the bacteria treatment only 
(  Figure 6a,   b ). IL-8 secretion significantly increased when GECs 
were pretreated with the combination of low doses of SB and 
TSA in response to   P. gingivalis   and   F. nucleatum,   which  was 
similar to the observation in CCL20 expression (  Figure 5c ). 
When GECs were pretreated with DNMT1 inhibitor AZA, no 
changes in IL-8 secretion were observed in the presence of two 
bacteria ( Figure 6d ). These data suggest that IL-8 secretion may 
be related to acetylation status in GECs.     
  Tri-methyl-histone H3 protein level is differentially regulated 
by   P. gingivalis   and   F. nucleatum   in GECs 
  Histone methylation has a pivotal role in the maintenance of 
both active and suppressed states of gene expression, depending 
on the sites of methylation. Methylation of Lys4 of histone 3 is 
generally associated with transcriptionally active chromatin.  19  
In order to evaluate the changes in histone H3 methylation level 
in GECs when exposed to bacteria, we detected endo  genous 
levels of histone H3 tri-methylated at Lys4 (H3K4me3) follow-
ing exposure to   P. gingivalis   or   F. nucleatum   for  24   h  at  MOI 
100:1. The protein amount was significantly decreased when 
GECs were stimulated with  P. gingivalis  compared with unstimu-
lated control, whereas the level of this protein had no significant 
change after exposure to  F. nucleatum  ( Figure 7 ) compared with 
the control. These results demonstrate differential induction of 
H3K4 methylation and further suggest that oral bacterial infec-
tion is associated with changes in H3K4 methyl  ation pattern.     
  Epigenetic modification of genes, whose function is 
associated with growth control and inflammation, is 
differentially regulated by   P. gingivalis   and   F. nucleatum   
  Gene promoter methylation is one of the most common 
epigenetic mechanisms to silence gene expression. In order to 
identify specific methylated genes associated with   P. gingivalis  
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  Figure 4                        mRNA expression of innate immune markers human 
    -defensin 2 (hBD-2) are increased when histone deacetylase (HDAC) 
and DNA methyltransferase (DNMT) are inhibited. Gingival epithelial cells 
(GECs) were pretreated with trichostatin A (TSA; 9 and 45    m  M  ), sodium 
butyrate (SB; 0.5 and 2.0    m  M  ) or 5    -azacytidine (AZA; 1 and 10          M  ) for 
4    h, and subsequently exposed to   Porphyromonas gingivalis   (multiplicity 
of infection (MOI) 100:1) or   Fusobacterium nucleatum   (MOI 100:1) for 
16    h. Gene expression of hBD2 was evaluated by quantitative real-time 
PCR (QRT-PCR) compared with unstimulated control after normalization 
with glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Controls 
include unstimulated control, bacteria-alone treatment, and various 
inhibitors alone as indicated. No significant changes were found in 
the gene expression of hBD2 in GECs treated with inhibitor only: (  a  ) 
SB, (  b  ) TSA, ( c  ) SB      +      TSA, and (  d  ) AZA compared with unstimulated 
control. Data are expressed as means of fold change  ±  s.e.m. from three 
donors evaluated in duplicate. Asterisks indicate statistically significant 
difference compared with unstimulated control (Ctl) (  *    P        <      0.05,   *    *    P        <      0.01).   MucosalImmunology | VOLUME 4 NUMBER 4 | JULY 2011   413
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or   F. nucleatum   infection, we examined the changes in methyl-
ation levels of 24 different cytokine-producing genes in TERT 
cells after the cells were exposed to   P. gingivalis   or   F. nucleatum  
for 24     h at MOIs 10:1, 100:1, and 200:1 (  Table 1  ). A dose-
dependent increase in methylation levels of the following genes 
was observed when GECs were exposed to  P. gingivalis :  CD276 , 
an immune regulator (  P     <    0.005);   elastase 2  , a serine protease 
that has a role in inflammatory diseases (  P     <    0.01);   INHBA  
(  inhibin,       ), a tumor-suppressing protein (  P     <    0.01);   GATA3  
(  GATA binding protein 3  ), a putative tumor suppres  sor 
(  P     <    0.005);   Toll-like receptor 2   ( TLR2 ;   P     <    0.005);  and 
  IL-12A   ( P     <    0.005).  Stimulation  of  GECs  with   P. gingivalis  
also resulted in hypomethylation of   ZNF287 ,  a  member 
of zinc-finger protein family, and   signal transducer and acti-
vator of transcription 5A   ( STAT5A ;   P     <    0.005),  which  mediates 
cellular responses to cytokines IL-2, IL-3, IL-7, and granulo-
cyte  –  macrophage colony-stimulating factor. On the other 
hand, the methyl ation levels of  elastase 2  ( P     <    0.005) and  GATA3  
(  P     <    0.01) decreased after cells were stimulated with  F. nucleatum . 
Interestingly, only   F. nucleatum   induced hypermethyl  ation of 
  MALT1   (mucosa-associated lymphoid tissue lymphoma trans-
location gene) in GECs. 
  We have observed that hBD2, CCL20, and chemokine IL-8 
are differentially modulated via epigenetic mechanism, and also 
found that multiple genes are differentially methylated after 
exposure to   P. gingivalis   or   F. nucleatum.   In order to further 
understand biological correlation among the genes that respond 
to the bacterial treatments, we used PubGene to identify bio-
logical relationship based on literature co-occurrence index 
(  Figure 8 ). The queried genes  DEFB4  ( hBD2 ),  CCL20 , and  IL-8  
are strongly associated with the genes that showed hypermethyl-
ation (  ELA2 ,   TRL2 ,   STAT5A ,   IL-12A ,  and   GATA3 )  based  on 
literature co-citation. This illustrates the complex coregulatory 
patterns of tested genes, and highlights the biological relevance 
for the tested genes.     
  Genes associated with chromatin modification changed in 
host cells that were treated with different oral bacteria 
  In order to broaden our understanding of which genes are 
involved with chromatin modifications in epithelial responses 
to bacteria, we performed microarray ontology analysis (BRB 
Array tool)  20   based on our previous study and on public data 
sets from NCBI (National Center for Biotechnology Information) 
Gene Expression Omnibus (accession number GSE6927).  21 – 23  
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      Figure 5                        mRNA expression of innate immune markers CC chemokine 
ligand 20 (CCL20) are increased when histone deacetylase (HDAC) and 
DNA methyltransferase (DNMT) are inhibited. Gingival epithelial cells 
(GECs) were pretreated with trichostatin A (TSA; 9 and 45    m  M  ), sodium 
butyrate (SB; 0.5 and 2.0    m  M  ), or 5    -azacytidine (AZA; 1 and 10          M  ) for 
4    h, and subsequently exposed to   Porphyromonas gingivalis   (multiplicity 
of infection (MOI) 100:1) or   Fusobacterium nucleatum   (MOI 100:1) 
for 16    h. Gene expression of (  b  ) CCL20 was evaluated by quantitative 
real-time PCR (QRT-PCR) compared with unstimulated control after 
normalization with glyceraldehydes-3-phosphate dehydrogenase 
(GAPDH). Controls include unstimulated control, bacteria-alone 
treatment, and various inhibitors alone as indicated. No significant 
changes were found in the gene expression of CCL20 in GECs 
treated with inhibitor only: (  a  ) SB, (  b  ) TSA, ( c  ) SB      +      TSA, and (  d  ) AZA 
compared with unstimulated control. Data are expressed as means of 
fold change   ±   s.e.m. from three donors evaluated in duplicate. Asterisks 
indicate statistically significant difference compared with unstimulated 
control (Ctl) (  *    P        <      0.05,   *    *    P        <      0.01).   414  VOLUME 4 NUMBER 4 | JULY 2011 | www.nature.com/mi
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A number of genes that are associated with chromatin modi-
fication were altered in host cells that were treated with 
  P. gingivalis  or  F. nucleatum  ( Table 2 ). The changes observed in 
histone deacetylases and DNA methyltransferases in response to 
  P. gingivalis   correspond to our mRNA data (  Figures 1 and 3 ). 
Thus, our findings using different molecular methods are 
consistent and suggest that various genes associated with 
epi  genetic modifications are differentially regulated when oral 
epithelial cells are exposed to oral bacteria.       
  DISCUSSION 
  In this study, we showed that the presence of bacteria 
results in epigenetic modifications in gingival epithelia. We also 
demonstrated that epigenetic modifications have a critical role 
in the regulation of innate immune responses of gingival epi-
thelia. Epigenetic modifications, such as DNA methylation and 
histone acetylation or methylation status, lead to altered gene 
expression and have been associated with cancer development 
and tumor growth. However, the role of epigenetic mechanism 
in host innate immune responses to bacteria  –  host interactions 
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    Figure 7                        Protein levels of histone H3 methylated at Lys4 were 
evaluated with PathScan enzyme-linked immunosorbent assay (ELISA). 
Gingival epithelial cells (GECs) were exposed to   Porphyromonas 
gingivalis   or   Fusobacterium nucleatum   for 24    h at multiplicity of infection 
(MOI) of 100:1, and then nuclear protein was extracted followed by 
sonication. The H3 tri-methylated at Lys4 was captured by coated 
antibody after incubation with cell lysates, and histone H3 protein 
level was quantified according to the absorbance readings at 450    nm. 
Protein expression was expressed as the ratio of absorbance readings 
normalized to relative protein amount. The data are average from three 
different donor cells tested with standard error deviation. The asterisks 
indicate the significant difference vs. the respective unstimulated control 
(  *    *    P        <      0.01).   
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        Figure 6                        Interleukin-8 (IL-8) secretion is increased when histone 
deacetylase (HDAC) and DNA methyltransferase (DNMT) are inhibited. 
Gingival epithelial cells (GECs) were pretreated with trichostatin A 
(TSA; 9 and 45    m  M  ), sodium butyrate (SB; 0.5 and 2.0    m  M  ), or 
5    -azacytidine (AZA; 1 and 10          M  ) for 4    h, and subsequently exposed 
to   Porphyromonas gingivalis   (multiplicity of infection (MOI) 100:1) 
or   Fusobacterium nucleatum   (MOI 100:1) for 16    h. Secretion of IL-8 
in response to various oral bacteria is evaluated by enzyme-linked 
immunosorbent assay (ELISA). Cell-free supernatant was collected 
and the amount of IL-8 secreted is shown in pg    ml    –  1  . Unstimulated cells 
(UN) are used as controls in each experiment. Data from duplicates with 
cells from three different donors are shown. No significant changes were 
found in the secretion of IL-8 in GECs treated with inhibitor only: (  a  ) SB, 
(  b  ) TSA, ( c  ) SB      +      TSA, and (  d  ) AZA compared with unstimulated control. 
Asterisks indicate statistically significant difference compared with 
unstimulated control (Ctl) (  *    P        <      0.05,   *    *    P        <      0.01).   MucosalImmunology | VOLUME 4 NUMBER 4 | JULY 2011   415
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has not been studied. Thus, our study addresses a novel and 
an important question of the role of epigenetics in epithelial 
innate immunity. Our data suggest that exposure to different 
oral bacteria results in differential methylation profile, and 
bacteria-induced expression of epithelial antimicrobial 
molecules hBD2 and CCL20 is regulated through epigenetic 
mechanisms in GECs. 
  Factors that influence epigenetic profile are wide ranging 
and include environmental toxins, individual diet, as well as 
microbial infections. Gastric cancer is one type of disease that 
has been identified as resulting from epigenetic modification 
following bacterial infection.  24   In the oral cavity, epithelial tis-
sues are constantly exposed to a variety of bacteria, and dif-
ferent bacteria elicit different innate immune responses from 
the host. These divergences may be seen between pathogens 
vs. nonpathogens and / or between various species of pathogens. 
We have previously reported that pathogens and nonpathogens 
utilize different signaling pathways in the induction of epithelial 
innate immune markers.  13,14   Because of the high number of 
bacteria present in the oral cavity at all times, we strongly sus-
pected that the presence of bacteria will influence the epigenetic 
status of the host. Our data showed that stimulation of GECs 
with   P. gingivalis   resulted in hypomethylation of   ZNF287  . The 
upregu lation of ZNF287 has been associated with cardiovascular 
disease;  25   thus, our observation is in line with recent studies 
linking perio  dontal disease with increased risk of systemic 
disease.  26   On the other hand,   F. nucleatum  , but not   P. gingivalis , 
induced hypermethylation of   MALT1   that stimulates IKK cata-
lytic acti vity, resulting in nuclear factor (NF-  B) activation. 27  The 
methyl ation of MALT1 is associated with the silencing of  MALT1  
gene, which is consistent with our previous data that  F. nucleatum  
does not utilize the NF-  B signaling pathway in the induction of 
innate immune responses.  13,14  Taken together, our data suggest 
that oral epithelia respond to the presence of different bacteria 
via differential epigenetic changes on various genes. 
  We showed both species of oral bacteria tested significantly 
decreased gene expression of chromatin-modifying enzyme 
DNMT1 in GECs. In contrast, we also observed that the two 
oral bacteria differentially induced hypermethylation of 
specific genes in GECs as listed in   Table 1  . The explanation 
for this discrepancy is that DNMT1 has an ability to promote 
only 20  %   of overall genomic methylation, although it is a major 
DNMT in humans.  28  In addition, two other enzymes, DNMT3a 
and DNMT3b, have also been shown to possess DNMT activity;  29  
thus, other methyltransferases may respond the same way. 
  HDAC inhibitors are known as agents that modulate the 
expression of genes by increasing histone acetylation, thereby 
regulating chromatin structure, transcription, and increas-
ing antimicrobial function of cathelicidin expression in skin 
        Table 1         Differential changes in the promoter methylation 
status of various cytokine-producing genes in response to 
  Porphyromonas gingivalis   vs.   Fusobacterium nucleatum   
        Bacteria       Increased methylation       Decreased methylation   
        P. gingivalis       CD276   (  P        <      0.005)    
  ELA2   (  P        <      0.01)    
  INHBA   (  P        <      0.01)    
  GATA  3 (  P        <      0.005)    
  TLR2   (  P        <      0.005)    
  IL-12A   (  P        <      0.005) 
    ZNF287   (  P        <      0.05)    
  STAT5A   (  P        <      0.005) 
        F. nucleatum       MALT1       ELA2   (  P        <      0.005)    
  GATA3   (  P        <      0.01) 
          Abbreviations:   ELA2  ,   elastase 2, neutrophil  ;   GATA3  ,   GATA binding protein 
3  ;   IL-12A  ,   interleukin 12A  ;   INHBA  ,   inhibin,       ;   MALT1, mucosa associated 
lymphoid tissue lymphoma translocation gene 1  ;   STAT5A  ,   signal transducer 
and activator of transcription 5A  ;   TLR2  ,   Toll-like receptor 2  ;   ZNF287  ,   zinc-ﬁ  nger 
protein 287  .     
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keratino  cytes. The similar phenomenon was also observed in 
gingival epithelium. In this study, we have found that inhibition 
of HDAC (SB) has no significant effects on GECs in response to 
both oral bacteria tested in terms of gene expression of hBD2 
and CCL20, whereas inhibition by TSA significantly induced 
gene expression in GECs in response to these bacteria. This may 
be because of the fact that TSA is a more potent HDAC inhibitor. 
More importantly, inhibition by both SB and TSA synergistically 
stimulated the gene expression of CCL20 in GECs in response to 
oral bacteria, further confirming that innate immune responses 
to oral bacteria are dependent on the deacetylation status 
of host. 
  HBD2 and CCL20 with innate immune properties have 
been well studied. HBD2, an inducible antimicrobial peptide, 
has been found to be active against a panel of oral bacteria and 
  Candida   species. 11,15   CCL20, a chemokine with antimicrobial 
regions structurally related to hBD2, has antimicrobial activity 
mainly against Gram-negative bacteria and has a critical role in 
pulmonary innate immunity.  30   Therefore, the present finding 
suggested that altered epigenetic modification could potentially 
increase antimicrobial activity and enhance innate immunity 
in GECs. 
  Recent studies have demonstrated that methylation of 
histone H3 at K4 is important for the initial activation of 
trans  cription, because methylation of histone H3 at K4 pre-
cedes histone acetylation.  19   Our data showed that   P. gingivalis  
significantly decreased tri-methylation histone H3 at K4 
protein expression, but   F. nucleatum   did not, indicating that 
  P. gingivalis   could suppress the activation of transcription, 
consistent with the   “  stealth-like  ”   properties of   P. gingivalis . 31  
Our previous finding also support that the secretion level of 
cytokines and chemokines is lower in   P. gingivalis -stimulated 
dendritic cells and GECs.  12,18  
  P. gingivalis  , a major etiological agent of chronic periodon-
tal diseases, produces a broad array of potential virulence fac-
tors: lipopolysaccharide, fimbriae, hemagglutinin, hemolysins, 
and gingipains.  32   These virulence factors could trigger GECs 
through pathogen-associated molecular pattern receptors such 
as TLR2 / TLR4 33  or protease-activated receptor 2,  34  which lead to 
the activation of transcription signaling pathways NF-   B, 
MAPK (mitogen-activated protein kinase), and MEK  /  ERK 
(mitogen-activated protein kinase kinase / extracellular regulated 
kinase).  14,35   It is becoming apparent that both recruitment of 
NF-   B to target promoters and NF-  B-induced transcriptional 
genes are modulated through chromatin modification.  36   The 
decrease of DNMT has been reported to be associated with 
impaired signaling through the ERK and JNK (c-Jun N-terminal 
kinase) pathways.  37   It is therefore likely that connections exist 
between these transduction signaling pathways and DNA methyl-
transferase and histone deacetylase. On the other hand, our 
gene network analysis depicted the relationships between the 
queried genes and other immune response genes in the same 
network. Innate immune markers   DEFB4   (hBD2),   CCL20  , 
  DEFB1   (hBD1),  DEFB103A   (hBD3), and  IL8   show inter mediate 
connections to methylated genes tested, and also show direct 
or indirect connection with the genes NF-   B  ( MYD88  ), TLR 
signaling (  TLR2   and   TLR4  ),  and  JAK / STAT  ( STAT5  ,   STA5A  , 
  STAT5B  ,  JAK2  , and  GATA1  ). In addition, several other cytokines 
(  IL-6  ,  IL-1B  , and  IL-4  ) and chemokines ( CCL19  ,  CCL21  ,  CCR7  , 
and   CCL2  ) are also involved in this network, which are impor-
tantly relevant for immunoregulation. Therefore, it appears 
that the possible interaction between innate immune responses 
and epigenetic events, and epigenetic changes might determine 
the   “ on ”   or   “ off ”   state  of  transcriptional  activity  of  signaling 
transduction pathways. However, the exact signal triggering 
epigenetic changes remains unclear. 
 It has been well known that many factors have contributed to 
the pathogenesis of periodontal disease. Genetic factors have 
a strong impact on the pathogenesis of disease developments; 
i.e., gene polymorphism of TLR is associated with susceptibil-
ity to chronic periodontitis.  38   However, increasing evidences 
have shown that the factors that influence the epigenome during 
the lifetime may also change the host response to environmen-
tal exposures, such as bacterial infection. It was reported that 
inflammatory signals that activate NF-    B have been shown to 
be involved in histone methylation and acetylation, resulting in 
the selective gene induction.  39   Epigenetic modifications alter 
patterns of gene expression, which in turn leads to various clini-
cal outcomes. For example, the alteration in DNA methylation 
status of the   Igf2   gene in murine placental tissues was associ-
ated with maternal infection with the periopathogenic bacteria 
  Campylobacter rectus . 10  This may be particularly relevant in the 
    Table 2         Altered expression of genes involved in histone modification and  /  or epigenetics following bacterial stimulation 
        Bacteria       Genes downregulated (gene symbol,   P-  value)       Genes upregulated (gene symbol,   P-  value)   
        Fusobacterium 
nucleatum   
    H2A histone family   (  H2AFY  ,   P        <      0.0002)    
  Helicase implicated in chromatin remodeling   (  HELLS  , 
  P        <      0.03)    
  Prohibitin  : modulator of transcriptional activities (  PHB  , 
  P        <      0.0001)    
  DNA methyltransferases   (  DNMT1  ,   P        <      0.02)    
  Protein arginine-N-methyltranferases     7   (  PRMT 7  ,   P        <      0.02)    
  Histone acetyltransferases 3   (  HDAC3  ,   P        <      0.004) 
        CXXC1   (  P        <      0.02)    
  Histone lysine demethylase   (  PHF8  ,   P        <      0.03)    
  IGF2   (  P        <      0.04)    
  Histone H3-K9 methyltransferase   (  SUV39H1  ,   P        <      0.003)    
  Arginine methyltransferase 1   (  CARM1  ,   P        <      0.03) 
        Porphyromonas 
gingivalis   
    DNA methyltransferases   (  DNMT3L  ,   P        <      0.01)    
  Histone deacetylases 1   (  HDAC1  ,   P        <      0.05)    
  Insulin-like growth factor 2   (  IGF2  ,   P        <      0.04)    
  PHB   (  P        <      0.01)    
  CpG-binding protein   (  CXXC1  ,   P        <      0.03) 
        CXXC1      
  PHB      
  H2AFY   (  P        <      0.04)    
  Hemk methyltransferase family member1   (  HEMK1  , 
  P        <      0.05) MucosalImmunology | VOLUME 4 NUMBER 4 | JULY 2011   417
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disease development of humans, as   C. rectus   exposure of the 
fetus has been found to be associated with preterm delivery,  40  
and impaired fetal growth has been associated with adult-onset 
diabetes and cardiovascular disease.  41  Furthermore, variations in 
epigenetic status will likely elicit diverse inflammatory responses 
in periodontal disease. An earlier study reported that epigenetic 
mechanisms have a major role in the inflammation processes, 
locally as well as systemically.  42   Prostaglandin-endoperoxide 
synthase-2 promoter methylation levels from periodontally 
inflamed gingival biopsies showed a significant increase when 
compared with noninflamed biopsy samples,  43   suggesting  that 
methylation status is associated with chronic inflammation. 
Andia   et al.  44   reported that hypomethylated status of   IL-8   gene 
promoter was associated with aggressive periodontitis. Taken 
together, the epigenetic modification would have a high impact 
on disease developments, and it would be of interest to under-
stand how epigenetic mechanism contribute to the pathogenesis 
of inflammation, and how local persistent chronic inflammation 
and systemic disease are connected.  45  
 Periodontitis is not just chronic inflammatory disease, but its 
persistent nature could also exert a significant systemic impact 
on health, such as atherosclerosis, aspiration pneumonia, diabe-
tes, adverse pregnancy outcomes, and rheumatoid arthritis.  46 – 49  
Although the strategies for prevention and therapies for the 
periodontal disease have improved recently, effective preven-
tion and treatments are still a challenge. It is well known that 
the pathogenesis of periodontal disease is initiated by bacteria 
populating the tooth-associated biofilm, but disruption of host 
innate immune response may be a major contributory factor for 
disease progression.  50  The traditional treatment for periodontal 
disease with direct targeting of pathogen or inflammation has 
limitations, as many treated patients develop recurrent disease 
and bacterial resistance. Thus, developing new therapeutic strat-
egy for chronic inflammation by inducing host innate immune 
response is highly desirable. 
 Various HDAC inhibitors and DNMT inhibitors have already 
been evaluated as therapeutic agents with the potential roles in 
cancer treatments.  2   Recently, agents derived from those inhibi-
tors have been shown to have effective therapeutic roles beyond 
cancer treatments, based on their anti-inflammatory proper-
ties.  51   For example, SB has been used to stimulate production 
of endogenous antimicrobials in the gut, which can promote 
the clearance of   Shigella  , leading to clinical improvement of 
chronic infection. In this study, we have found that the inhibi-
tion of chromatin-modifying enzymes HDAC and DNMT have 
varying degrees of roles in the induction of antimicrobial func-
tion in GECs in response to various oral bacteria, suggesting the 
potential role of immune therapy of these inhibitors through 
epigenetic modification in oral cavity. 
  In this study we report for the first time how epigenetic 
mechanism has an important role in the expression of antimi-
crobial molecules in bacteria  –  host cell interactions. In sum-
mary, our data identified several potentially important effects 
of oral bacteria on epigenetic state of GECs and provide new 
insights that are critical for innate immune and inflammatory 
responses. We anticipate that the work of this study will lead to 
new understanding of coordinated interplay between epigenetic 
mechanisms, gene expression, and environment that can be 
translated into development of innovative treatments targeted for 
periodontitis.   
  METHODS         
  Reagents      .     The inhibitors for histone deacetylase, SB (0.5 and 2.0     m  m  ) 
and TSA (0.5 and 9   n m ), and for DNA methylation, AZA (1 and 10      m ), 
were from Sigma-Aldrich (St Louis, MO). Primary antibodies used 
were anti-DNMT1, anti-HDAC1, HDAC2 (mouse monoclonal anti-
body; Active Motif, Carlsbad, CA), and anti-actin (mouse monoclonal; 
Active Motif). Secondary antibody was anti-mouse IgG horseradish 
peroxidase-conjugated antibody from Jackson Immune Research (West 
Grove, PA).   
  Human primary GECs, human immortalized keratinocytes (TERT), 
and bacteria culture   .    Gingival  biopsies  were  obtained  from  healthy 
patients who underwent third-molar extraction in the Department of 
Oral Surgery, School of Dentistry, University of Washington, in accord-
ance with the University of Washington institutional review board-
approved study. Epithelial cells were cultured in keratinocyte growth 
medium with 0.15   m m  Ca 2    +      using the supplements from the keratinocyte 
growth medium-bullet kit (Cambrex, Walkersville, MD) at 37       °  C in a 
humidified atmosphere containing 5 %  CO  2 . 
 TERT cells were cultured in serum-free medium (GIBCO / Invitrogen, 
Carlsbad, CA), supplemented as described previously  52  with 25     g   ml  – 1  
bovine  pituitary  extract,  0.2   ng   ml  – 1   epidermal growth factor, and 
0.4   mmol   l  – 1  CaCl 2 . 
  P. gingivalis  (ATCC (American Type Culture Collection, Manassas, VA) 
33277) was cultured under anaerobic conditions (85 %  N  2 , 10 %  H 2 , and 5 %  
CO  2 ) at 37    ° C in Trypticase soy broth (BBL, Sparks, MD) supplemented 
with 1   g of yeast extract, 5   mg of hemin, and 1   mg of menadione per liter . 
F. nucleatum   (ATCC 25586) was grown in Todd-Hewitt broth supple-
mented with 1   g of yeast extract per 100   ml at 37    ° C under anaerobic con-
ditions. Bacterial purity was determined by Gram staining, and numbers 
were estimated by absorbance measurement using the TECAN GENios 
Multidetection Reader, V.4.51 (Phoenix, Hayward, CA). The bacteria 
were cultured to late logarithmic growth phase. GECs and TERT cells 
were grown to 85  %   confluence and stimulated with various stimuli as 
indicated. Bacteria were used at an amount equivalent to the indicated 
MOI. Each stimulation experiment was performed in duplicate, and cells 
from two to four different donors were tested.    
  QRT-PCR      .     Total RNA was isolated from GECs using RNeasy mini kit 
(Qiagen, Valencia, CA). Complementary DNA was prepared from 0.5     g 
total RNA. Quantitative analysis of the complementary DNA was per-
formed using an iCycler iQ5 (Bio-Rad, Hercules, CA). QRT-PCR was con-
ducted with SYBR Green Supermix kit from Bio-Rad. Melt-curve analysis 
was performed to confirm that the signal was of the expected amplifica-
tion product. The sequences of oligonucleotide primers for hBD2 and 
CCL20 were described previously (Yin and Dale  21  ). The sequences of 
HDAC1, HDAC2 and DNMT1 are: HDAC1 forward sequence 5   -CAT
CTCCTCAGCATTGGCTT-3    , HDAC1 reverse sequence 5   -CGAA
TCCGCATGACTCATAA-3    , HDAC2 forward sequence 5   -ATGAG
GCTTCATGGGATGAC-3   ,  HDCA2  reverse  sequence  5  -ATGGCG
TACAGTCAAGGAGG-3   , DNMT1 forward sequence 5  -CCTGTACC
GAGTTGGTGATGGT-3    , DNMT1 reverse sequence 5   -CCTTCCGT
GGGCGTTTC-3    , GAPDH (glyceraldehydes-3-phosphate dehydro-
genase) forward sequence 5  -AATGAAGGGGTCATTGATGG-3  , and 
GAPDH reverse sequence 5  -AAGGTGAAGGTCGGAGTCAA-3  . Each 
sample was normalized to the level of GAPDH transcript. The calculation 
for relative fold changes was described previously.  21    
  Cytokine secretion assay   .    Cell  culture  supernatants  after  vari-
ous stimulations were collected, and the level of IL-8 secretion was 
measured with an enzyme-linked immunosorbent assay kit (R & D Systems, 418  VOLUME 4 NUMBER 4 | JULY 2011 | www.nature.com/mi
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Minneapolis, MN) in accordance with the manufacturer  ’  s protocol. 
A standard curve was generated with each set of samples assayed. 
The optical density value of blank control (reagent diluents) was sub-
tracted from the measured optical density of the different standards 
and samples. Final concentrations in each sample were calculated as 
the mean of the results at the proper sample dilution yielding optical 
densities in the linear parts of the standard curves. Supernatants of cells 
from three different donors were tested, with duplicate samples from 
each donor.    
  Western blotting      .     Protein levels of DNMT1, HDAC1, and HDAC2 in 
GECs were assessed by western blot analyses. Briefly, GECs were treated 
with various bacterial stimulations (MOI 100:1), and nuclear extracts 
were prepared using Nuclear Extraction Kit from Active Motif. Nuclear 
protein concentration was determined using bicinchoninic protein assay 
kit (Thermo Fisher Scientific, Rockford, IL), and samples were resolved 
on  pre-cast  NuPAGE  Bis-Tris  10 – 12 %   denaturing  polyacrylamide  gels 
(Invitrogen, Carlsbad, CA), which were transferred to methanol-activated 
Immobilon-P polyvinylidene difluoride membranes (Millipore, Billerica, 
MA) and probed with specific primary antibodies. Nuclear extracts of 
HeLa cells (Active Motif) were used as positive controls. The signals were 
detected by chemiluminescence (Thermo Fisher Scientific) and exposure 
to X-ray film (Thermo Scientific, Rockford, IL).    
  Analysis of DNA methylation   .    Genomic  DNA  was  prepared  from 
human TERT cells using Perfect Pure DNA Cultured Cell kit from 
5 Prime (Gaithersburg, MD) according to the manufacturer ’ s instruction. 
To analyze DNA methylation of PCR array, 0.5         g genomic DNA was 
performed for the digestion of unmethylated and methylated DNA, using 
methylation-sensitive and methylation-dependent restriction enzymes. 
The remaining DNA after digestion is quantified by real-time RT-PCR, 
using primers that specifically flank the region of interest (Human 
Cytokine production, Methyl-Profile PCR Arrays; SABiosciences, 
Frederick, MD). PCR array plates were processed in a Bio-Rad iCyler 
Real-Time PCR System, using automated baseline and threshold cycle 
detection. Data were analyzed using the Excel-based PCR array data anal-
ysis template from SABiosciences. For this analysis, the relative concen-
trations of differentially methylated DNA (specifically, hypermethylated, 
unmethylated, and intermediary methylated DNA) are determined by 
comparing the amount of each digest with that of a mock digest. The data 
are expressed as the mean of the percent hyper-methylated DNA. All our 
experiments were repeated twice using TERT cells.    
  Tri-methyl histone H3 (lys4) protein measurement   .     G E C s  
were treated as indicated previously, and the cells were washed with 
cold phosphate-buffered saline and harvested using cell lysis buffer 
including fresh phenylmethylsulfonyl fluoride (Cell Signaling, Danvers, 
MA). Cell lysates were prepared followed by brief sonication. The 
levels of tri-methyl histone (lys4) proteins were measured with PathScan 
(Cell Signaling) enzyme-linked immunosorbent assay in accordance with 
the manufacturer ’ s protocol.   
  Gene networks analysis   .    PubGene  Bio-networks  ( http://www.
pubgene.com/public.html  ) were used to search for literature gene net-
works.  53   This program provides biomedical knowledge from publicly 
available gene and databases, and creates a gene-to-gene co-citation 
network.   
  Data analysis   .    Each  experiment  was  performed  with  cells  from  at 
least two to three different donors, and within an experiment, each test 
condition was performed in duplicate. Values are shown as the mean  ± 
s.e.m. from multiple experiments. Statistical significance was deter-
mined using one-way analysis of variance (JMP for Windows Release 
6.0; SAS Institute, Cary, NC) among the groups followed by the two-tailed 
Student ’ s  t -test (Excel Window 2007, Seattle, WA). Differences were con-
sidered to be statistically significant at the cutoff level of  P     <    0.05.       
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